BRCA2 and neoplasm: It is crucial to understand the pathogenetic mechanisms underlying the mutations in the BRCA1 and BRCA2 genes and how these are qualitatively and quantitatively linked to the risk of developing pre-tumour lesions like STIC and gynaecological cancers.